GSK plcGSKNYSE
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank13
Year-over-Year Change
Year-over-year book value per share growth
Percentile
P13
Within normal range
vs 5Y Ago
-3.7x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -24.29% |
| Q4 2025 | 8.58% |
| Q2 2025 | 12.30% |
| Q1 2025 | 34.45% |
| Q4 2024 | -2.75% |
| Q3 2024 | -22.73% |
| Q2 2024 | 3.90% |
| Q1 2024 | 2.13% |
| Q4 2023 | 5.87% |
| Q3 2023 | -0.41% |
| Q2 2023 | 10.28% |
| Q1 2023 | 38.19% |
| Q4 2022 | 3.66% |
| Q3 2022 | -64.66% |
| Q2 2022 | 106.38% |
| Q1 2022 | -54.12% |
| Q4 2021 | -1.43% |
| Q3 2021 | -1.70% |
| Q2 2021 | 2.61% |
| Q1 2021 | 1.67% |
| Q4 2020 | 6.65% |
| Q3 2020 | 7.10% |
| Q2 2020 | -0.39% |
| Q1 2020 | 2.22% |
| Q4 2019 | 34.60% |
| Q3 2019 | 508.20% |
| Q2 2019 | -12.18% |
| Q1 2019 | -8.49% |
| Q4 2018 | -1.43% |
| Q3 2018 | 23.08% |
| Q2 2018 | -15.98% |
| Q1 2018 | 2.64% |
| Q4 2017 | -27.76% |
| Q3 2017 | 8.48% |
| Q2 2017 | -20.62% |
| Q1 2017 | 12.46% |
| Q4 2016 | 24.09% |
| Q3 2016 | -6.01% |
| Q2 2016 | -35.21% |
| Q1 2016 | -26.51% |